Andrew Gundlach obtained his PhD from The University of Melbourne in 1982 and then undertook postdoctoral studies on neurotransmitter, peptide and drug receptors in Baltimore, Sydney and Cambridge, with support from the NHMRC (Australia). He then returned to the Department of Medicine, The University of Melbourne, where he was appointed an NHMRC Senior Research Fellow in 1992 to conduct studies of the molecular and cellular neuroscience of transcription factor and peptide gene expression and regulation. He was recruited to the Howard Florey Institute in 2000 and currently leads the Peptide Neurobiology Laboratory in the Neuropeptides Division of The Florey Institute of Neuroscience and Mental Health. His recent research has focused on the neurobiology of relaxin family peptides and their receptors, particularly relaxin-3 and its cognate G-protein coupled receptor, RXFP3. His team is applying anatomical, pharmacological and viral-based approaches in normal, transgenic and pathological animal models to elucidate the neurochemical and behavioural roles of relaxin-3/RXFP3 signalling.